Cortex Announces RESOLVE-AF Trial Evaluating Electrographic Flow® (EGF®) Mapping for use in Atrial Fibrillation Ablation

/PRNewswire/ -- Cortex announced today the initiation of its RESOLVE-AF trial (NCT05883631), a study formally launched in late October 2023. The international,...

Related Keywords

,Wilber Su ,Kent Nilsson ,David Haines ,University Of Arizona ,University Medical Center ,Mapping Catheter ,Principal Investigator ,Heart Rhythm Center ,Corewell Health ,Royal Oak ,Cardiac Electrophysiology ,Banner University Medical Center ,Associate Professor ,Cortex ,